Correlation Between Biomea Fusion and Viking Therapeutics
Can any of the company-specific risk be diversified away by investing in both Biomea Fusion and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomea Fusion and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomea Fusion and Viking Therapeutics, you can compare the effects of market volatilities on Biomea Fusion and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomea Fusion with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomea Fusion and Viking Therapeutics.
Diversification Opportunities for Biomea Fusion and Viking Therapeutics
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Biomea and Viking is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Biomea Fusion and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Biomea Fusion is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomea Fusion are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Biomea Fusion i.e., Biomea Fusion and Viking Therapeutics go up and down completely randomly.
Pair Corralation between Biomea Fusion and Viking Therapeutics
Given the investment horizon of 90 days Biomea Fusion is expected to under-perform the Viking Therapeutics. In addition to that, Biomea Fusion is 1.3 times more volatile than Viking Therapeutics. It trades about -0.25 of its total potential returns per unit of risk. Viking Therapeutics is currently generating about -0.31 per unit of volatility. If you would invest 6,297 in Viking Therapeutics on September 12, 2024 and sell it today you would lose (1,376) from holding Viking Therapeutics or give up 21.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biomea Fusion vs. Viking Therapeutics
Performance |
| Timeline |
| Biomea Fusion |
| Viking Therapeutics |
Biomea Fusion and Viking Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biomea Fusion and Viking Therapeutics
The main advantage of trading using opposite Biomea Fusion and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomea Fusion position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.| Biomea Fusion vs. Edgewise Therapeutics | Biomea Fusion vs. Werewolf Therapeutics | Biomea Fusion vs. Cullinan Oncology LLC | Biomea Fusion vs. Design Therapeutics |
| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stocks Directory Find actively traded stocks across global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |